Drug intelligence / Profile preview

biofactor combination

Development stage: Unknown
Lead developer: Wörwag Pharma
Administration: Oral

Overview

The biofactor combination is an investigational nutritional supplement developed by Wörwag Pharma GmbH & Co. KG. It consists of a specific blend of vitamins and minerals, aligned with the company's 'biofactor' philosophy which focuses on essential micronutrients like vitamins, minerals, and trace elements. The supplement is currently being evaluated in a randomized, double-blind, placebo-controlled Phase IIa pilot trial in collaboration with Swinburne University of Technology. The primary objective of the study is to assess the effects of daily supplementation over 24 weeks on cognitive function in patients with mild cognitive impairment (MCI), aiming to stabilize cognitive health and potentially delay the progression to Alzheimer's disease.

Other names: Biofactor Combination in Mild Cognitive Impairment

Beyond the preview

Go deeper on biofactor combination.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on biofactor combination.

Explore the full profile